uPAR-targeted CAR T cells show broad vulnerability in solid tumors with TP53/RAS mutations in preclinical models
Synergizing with senescence-inducing therapies, uPAR CAR T cells eradicate primary and metastatic solid tumors with minimal myelodepletion by targeting both tumor cells and the stroma in preclinical…
Read the full articleYou might also wanna read
Antibody-ligand motif optimization enables multitarget switchable CAR-T therapy against solid tumors
Wang et al. designed a sCAR-T to overcome solid tumor heterogeneity and the tumor microenvironment. The fusion of scFv with ligands enables
Dual tumour–myeloid targeting of glioblastoma with GPNMB CAR-T cells
Nature, Published online: 01 July 2026; doi:10.1038/s41586-026-10641-1 Integrated multi-omic profiling of glioblastoma reveals GPNMB as a sh
AI-guided discovery identifies GPNMB as promising CAR T cell target for multiple cancers
An AI-guided framework integrating high-resolution cellular atlases, public knowledge databases, and large language models enables a modular
A Multicenter, Open-label, Non-randomized, Single-arm Phase 1/2 Study of Autologous Nano CD5-CAR T Cells for the Treatment of Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma
Conditions : T-Cell Acute Lymphoblastic Leukemia; T-Lymphoblastic Lymphoma; Relapsed/Refractory Hematologic Malignancies Interventions : Bio
An Early Clinical Study to Evaluate the Safety and Efficacy of CLDN18.2 CAR T Cell Injection in Subjects With CLDN18.2-Positive Advanced Malignant Solid Tumors
Conditions : CLDN18.2 Positive Solid Tumors Interventions : Biological: SUV2208A cell injection; Biological: SUV2208A; Biological: SUV2208A
Científicos financiados por los Institutos Nacionales de la Salud descubren pistas sobre las lesiones precancerosas y la biología tumoral
En nuevos estudios publicados por la Red del Atlas de Tumores Humanos (HTAN) del Instituto Nacional del Cáncer (NCI), se explora la función
Comments
Sign in to join the conversation.
No comments yet. Be the first.